Merit Medical Systems Inc (MMSI)

Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA and an Investment Account
Sell

$60.00

Buy

$157.96

arrow-up$1.26 (+1.29%)

Merit Medical Systems Inc designs, develops, manufactures and sells medical devices used in interventional and diagnostic procedures. Its products are used in thoracic surgery, interventional nephrology, vascular surgery, and oncology and pain management.
Prices updated at 16 May 2025, 21:20 EDT
| Prices minimum 15 mins delay
|
Prices in USD
NASDAQ
arrow-up0.52%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Income statement

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
728m883m995m964m1,075m1,151m1,257m1,357m
326m395m432m401m485m519m584m643m
46m59m39m46m78m101m127m156m
6.286.713.974.767.298.7810.1411.51
28m42m5m-10m48m75m94m120m
97m129m119m104m155m181m229m296m
Sales, General and administrative229m276m327m298m336m343m374m400m
Interest expenses8m10m13m10m5m6m16m31m
Provision for income taxes8m8m-3m-3m5m8m18m30m
Operating expenses281m336m393m355m407m418m456m487m
Income before taxes36m50m2m-13m54m83m112m150m
Net income available to common shareholders28m42m5m-10m48m75m94m120m
0.560.80.1-0.180.861.311.642.07
Net interest income-7m-9m-13m-9m-4m-6m-13m-5m
Advertising and promotion--------
Net investment income, net--------
Realised capital gains (losses), net--------
Total benefits, claims and expenses--------
Earnings per share (diluted)0.550.780.1-0.180.841.291.622.03
Free cash flow per share0.45890.4394-0.05611.73651.85421.53881.17162.9368
Book value/share13.270516.818417.192316.788717.913719.000521.25722.5287
Debt equity ratio0.3829660.4000450.5312920.4325830.2845960.2153930.7315070.568622

Balance sheet

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
Current assets316m430m455m430m482m529m1,108m924m
Current liabilities116m175m182m185m236m221m204m216m
Total capital935m1,306m1,382m1,302m1,274m1,331m2,025m2,109m
Total debt278m395m524m435m315m269m891m795m
Total equity676m933m950m959m1,040m1,144m1,202m1,379m
Total non current liabilities--------
Loans259m373m432m344m234m187m823m730m
Total assets1,112m1,620m1,757m1,664m1,648m1,664m2,325m2,419m
Total liabilities--------
Cash and cash equivalents32m67m44m57m68m58m587m377m
Common stock50m55m55m56m57m57m58m59m

Cash flow

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
Cash at beginning of period19m32m67m44m57m68m61m589m
Cash dividends paid--------
22m20m-4m116m116m66m108m183m
Investments (gains) losses-147m-379m-134m-59m-37m-57m-175m-369m
32m67m44m57m68m61m589m379m
Net income--------
63m87m78m165m147m114m145m221m
-41m-66m-81m-49m-31m-48m-37m-38m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.